PCOS Research Study
Dr. Anuja Dokras and the PCOS Center at the University of Pennsylvania is running a research study for individuals with polycystic ovarian syndrome (PCOS) and non-alcoholic fatty liver disease (NAFLD).
Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease which is characterized by liver injury and inflammation. PCOS is a common endocrine abnormality in women of reproductive age and is characterized by affecting ovulation and excessive hair growth in women.
The study will involve approximately 24-weeks of treatment using an investigational drug, Saroglitazar Magnesium. Saroglitazar Magnesium is investigational and has not been approved by the U.S. Food and Drug Administration. The purpose of this study is to evaluate the efficacy and safety of Saroglitazar Magnesium 4 mg tablet once daily in women with well characterized PCOS diagnosed with NAFLD.
If you are eligible to participate you have a 50% chance of receiving the study drug or a placebo (sugar pill).
Study participants must:
Be between 18-45 years of age
Have a diagnosis of PCOS
Have NAFLD or Suspected NAFLD
Study involvement may include:
Frequent Clinic Visits
Physical and Gynecological Exams
MRIs and FibroScans
Study Medication or Placebo
Compensation for time and travel
For more information please click HERE or call 215.662.7727.
Principal Investigator: Anuja Dokras, MD, PhD